Steward Partners Investment Advisory, LLC Innoviva, Inc. Transaction History

Steward Partners Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$14.32 - $19.88 $75,323 - $104,568	-5,260 Reduced 98.8%	64 $1,000
Q1 2022 May 02, 2022	SELL	$15.39 - $20.25 $5,309 - $6,986	-345 Reduced 6.09%	5,324 $103,000
Q4 2021 Feb 08, 2022	SELL	$15.91 - $18.72 $2,656 - $3,126	-167 Reduced 2.86%	5,669 $98,000
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $8,136 - $10,740	623 Added 11.95%	5,836 $98,000
Q2 2021 Aug 13, 2021	BUY	$11.45 - $13.96 $59,688 - $72,773	5,213 New	5,213 $70,000

228

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.